Regular article
Glutamine Immunoreactivity in Müller Cells of Monkey Eyes with Experimental Glaucoma

https://doi.org/10.1006/exer.1997.0447Get rights and content

Abstract

The action of glutamate in retina is largely terminated through rapid uptake by Müller cells and subsequent conversion primarily to glutamine. Glutamine, transferred from Müller cells to neurons, serves as a precursor for the formation of glutamate in neurons completing the glutamate-glutamine cycle. In a monkey model of high-tension glaucoma, we have examined glutamine immunoreactivity in the Müller cell as well as the number of Müller cells to determine whether the activity of these cells in the glutamate-glutamine cycle is affected, particularly since high vitreal glutamate has been reported in glaucoma. Unilateral glaucoma was induced in three monkeys by argon laser application to the trabecular meshwork. LR White sections of retina from the temporal mid-periphery (about 23°) and the parafovea (central 3°) were immunolabeled for glutamine using immunogold and silver intensification. The percentage difference in labeling intensity (darkness) in the glaucomatous retina was determined relative to the labeling found in the control retina by image analysis. Ganglion cell density was estimated from radial sections in the parafovea and from retinal whole mounts in the mid-periphery. The number of Müller cells was estimated from vibratome sections immunolabeled by vimentin antibodies in the temporal mid-periphery (about 30°). Glutamine immunoreactivity was localized predominately in ganglion cells and Müller cells. However, the intensity of glutamine immunolabeling was greater in Müller cells of glaucomatous eyes than in control eyes. This increase in glutamine immunolabeling was 25–32% in the temporal mid-periphery and 27–48% in the parafovea. Müller cell number in the glaucomatous eye was similar to that of the control in the temporal mid-periphery. The data in this study indicate that the increase in glutamine in Müller cells is not a consequence of their loss and that Müller cell function in the glutamate-glutamine cycle continues in glaucomatous eyes. These findings are consistent with a previous report that extracellular/vitreal glutamate concentration is elevated in high-tension glaucoma.

References (34)

  • L.J. Frishman et al.

    The scotopic electroretinogram of macaque after retinal ganglion cell loss from experimental glaucoma

    Invest. Ophthalmol. Vis. Sci.

    (1996)
  • D.E. Gaasterland et al.

    Experimental glaucoma in the rhesus monkey

    Invest. Ophthalmol.

    (1974)
  • Y. Glovinsky et al.

    Retinal ganglion cell loss is size dependent in experimental glaucoma

    Invest. Ophthalmol. Vis. Sci.

    (1991)
  • C.K. Hampton et al.

    Autoradiographic analysis of333

    J. Neurosci. Res.

    (1983)
  • C.-J. Jeon et al.

    Selective accumulation of diamidino yellow and chromomycin A3

    J. Histochem. Cytochem.

    (1993)
  • M. Kalloniatis et al.

    Amino acid signatures in the primate retina

    J. Neurosci.

    (1996)
  • D.R. Lucas et al.

    The toxic effects of sodiuml

    Am. Assoc. Arch. Ophthalmol.

    (1957)
  • Cited by (40)

    • Neuroinflammation in Glaucoma and Optic Nerve Damage

      2015, Progress in Molecular Biology and Translational Science
      Citation Excerpt :

      The unique distribution of Müller cells through the thickness of the retina allows them to interact with every cell type in the tissue, rendering these glial cells hypersensitive to changes in the retinal environment. These macroglial cells are the most abundant glial cell in the retina and encompass a number of important roles including recycling the neurotransmitter glutamate,63 an excess of which is toxic to the retina,109 and in response to glaucoma or damage, Müller glia upregulate the enzyme catalyzing this process, glutamine synthetase.63,110 Activated Müller cells also upregulate GFAP, which manifests as visible filaments through cross sections of retinal tissue,63,81 and express growth factors, neurotrophic factors, neurotransmitter transporters, and antioxidant agents that are thought to combat damaging stimuli and protect RGCs.62

    • Akt is activated via insulin/IGF-1 receptor in rat retina with episcleral vein cauterization

      2004, Brain Research
      Citation Excerpt :

      RGC death mechanisms in human glaucoma and experimental models of glaucoma have been shown to involve apoptosis [19,26,42,45]. Some specific initiators of apoptosis may include blockage of axonal transport leading to neurotrophin depletion [40,43], glutamate excitotoxicity [9], and nitric oxide synthase up-regulation with reactive oxygen species formation [38]. Several signal transduction pathways have been identified that can mediate neural cell survival and plasticity.

    View all citing articles on Scopus

    Osborne, N. N.Chader, G. J.

    f1

    Address for correspondence and/or reprint requests: Dr Louvenia Carter-Dawson, The University of Texas-Houston Health Science Center, 6431 Fannin, Suite 7.024, Department of Ophthalmology and Visual Science Houston, Texas 77030, U.S.A.

    View full text